Working… Menu

Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00516100
Recruitment Status : Unknown
Verified January 2010 by Aptium Oncology Research Network.
Recruitment status was:  Active, not recruiting
First Posted : August 14, 2007
Last Update Posted : January 15, 2010
Millennium Pharmaceuticals, Inc.
Information provided by:
Aptium Oncology Research Network

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : January 2010
Estimated Study Completion Date : August 2012